The significance of the nutritional factor in atrial fibrillation

Authors: Bogdanov A.R., Romanova T.A.

Company: 1 N.I. Pirogov Russian National Research Medical University, Moscow, Russian Federation
2 Russian State Social University, Moscow, Russian Federation
3 City Clinical Hospital No.13, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2022-16-4-443-454

For citation: Bogdanov A.R., Romanova T.A. The significance of the nutritional factor in atrial fibrillation. Creative Cardiology. 2022; 16 (4): 443–54 (in Russ.). DOI: 10.24022/1997-3187-2022-16-4-443-454

Received / Accepted:  18.11.2022 / 12.12.2022

Keywords: diet therapy obesity personalized diet therapy Mediterranean diet atrial fibrillation

Full text:  

 

Abstract

Review summarizes current scientific data on the possibility of rational alimentary prophylaxis and diet therapy for patients with atrial fibrillation (AF). The article provides a scientific literature review of the relationship of various nutritional factors and diets with AF. In particular, it has been shown that proven nutritional risk factors for the development of AF are excessive calorie intake, alcohol abuse, and a lack of potassium and magnesium intake. Nutrients and food products that have the potential to prevent supraventricular arrhythmias, including AF, are considered in detail. The possibility of using in the treatment of AF diets aimed at reducing body weight in obesity, such as low-carbohydrate, low-fat, high-protein and ketogenic diets, as well as the Mediterranean diet, which has the most proven cardioprotective characteristics, is discussed.

The authors conclude that the greatest potential for alimentary prevention and dietary therapy of AF probably has a personalized approach based on the patient's individual needs for nutrients and energy, taking into account the principles of organizing the Mediterranean diet, reducing calories mainly due to the fat quota, excluding foods with trigger potential and enriched with cardioprotective nutritional components. The algorithm for personalization of dietary therapy needs further development.

References

  1. Benjamin E.J., Muntner P., Alonso A., Bittencourt M.S., Callaway C.W., Carson A.P. et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation. 2019; 139: е56 – 528. DOI: 10.1161/CIR.0000000000000659
  2. Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Russian Journal of Cardiology. 2021; 26 (9): 4701 (in Russ.). DOI: 10.15829/1560-4071-2021-4701
  3. Schnabel R.B., Yin X., Gona P., Larson M.G., Beiser A.S., McManus D.D. et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015; 386: 154–62. DOI: 10.1016/S0140-6736(14)61774-8
  4. Di Carlo A., Bellino L., Consoli D., Mori F., Zaninelli A., Baldereschi M. et al. National Research Program: Progetto FAILFAiI. Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project. Europace. 2019; 21: 1468–75. DOI: 10.1093/europace/euz141
  5. Atrial fibrillation and flutter. Clinical guidelines. Ministry of Health of the Russian Federation. 2020 (in Russ.).
  6. Golukhova E.Z., Gromova O.I., Bulaeva N.I., Arakelyan M.G., Lifanova L.S., Shlyappo M.A. et al. Epicardial fat and atrial fibrillation: the role of profibrinogenic mediators. Kardiologiia. 2018; 58 (7): 59–65 (in Russ.). DOI: 10.18087/cardio. 2018.7.10145
  7. Golukhova E.Z., Malinova I.M., Kakuchaya T.T. Cardiac arrhythmias in patients with obstructive sleep apnoea: clinical features, diagnosis and treatment. Annaly Aritmologii. 2006; 3 (2): 66–71 (in Russ.).
  8. Wang T.J., Parise H., Levy D., D’Agostino R.B. Sr, Wolf P.A., Vasan R.S. et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004; 292: 2471–7. DOI: 10.1001/jama.292.20.2471
  9. Kruszewska J., Cudnoch-Jedrzejewska A., Czarzasta K. Remodeling and fibrosis of the cardiac muscle in the course of obesity – pathogenesis and involvement of the extracellular matrix. Int. J. Mol. Sci. 2022; 23 (8): 4195. DOI: 10.3390/ijms23084195
  10. Wong C., Ganesan A., Selvanayagam J.B. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur. Heart J. 2016; 38: 1294–302. DOI: 10.1093/eurheartj/ehw045 11. Stamler R., Stamler J., Riedlinger W.F., Algera G., Roberts R.H. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA. 1978; 240: 1607–10. DOI: 10.1001/jama.1978.03290150053024
  11. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S. et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. 2001. JAMA. 2003; 289: 76–9. DOI: 10.1001/jama.289.1.76
  12. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P. et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005; 366: 1640–9. DOI: 10.1016/S0140- 6736(05)67663-5
  13. Apovian C.M. What’s new about the new US obesity guidelines? Curr. Obes. Rep. 2014; 3 (2): 147–9. DOI: 10.1007/s13679-014-0103-1
  14. Hung C.L., Gonc5 alves A., Lai Y.J., Lai Y.H., Sung K.T., Lo C.I. et al. Light to moderate habitual alcohol consumption is associated with subclinical ventricular and left atrial mechanical dysfunction in an asymptomatic population: dose-response and propensity analysis. J. Am. Soc. Echocardiogr. 2016; 29: 1043–51. DOI: 10.1016/j.echo.2016.07.014
  15. Voskoboinik A., Costello B.T., Kalman E., Prabhu S., Sugumar H., Wong G. et al. Regular alcohol consumption is associated with impaired atrial mechanical function in the atrial fibrillation population: a cross-sectional MRI-based study. JACC Clin. Electrophysiol. 2018; 4: 1451–9. DOI: 10.1016/j.jacep.2018.07.010
  16. Larsson S.C., Drca N., Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J. Am. Coll. Cardiol. 2014; 64: 281–9. DOI: 10.1016/j.jacc. 2014.03.048
  17. Giannopoulos G., Anagnostopoulo I., Kousta M., Vergopoulos S., Deftereos S., Vassilikos V. Alcohol consumption and the risk of incident atrial fibrillation: a meta-analysis. Diagnostics. 2022; 12: 479. DOI: 10.3390/diagnostics12020479
  18. Ding C., O’Neill D., Bell S., Stamatakis E., Britton A. Association of alcohol consumption with morbidity and mortality in patients with cardiovascular disease: original data and meta-analysis of 48,423 men and women. BMC Med. 2021; 19: 167. DOI: 10.1186/s12916-021-02040-2
  19. Yoon S.J., Jung J.G., Lee S., Kim J.S., Ahn S.K., Shin E.S. et al. The protective effect of alcohol consumption on the incidence of cardiovascular diseases: is it real? A systematic review and metaanalysis of studies conducted in community settings. BMC Public Health. 2020; 20: 90. DOI: 10.1186/s12889-019-7820-z
  20. Voskoboinik A., Kalman J.M., De Silva A., Nicholls T., Costello B., Nanayakkara S. et al. Alcohol abstinence in drinkers with atrial fibrillation. N. Engl. J. Med. 2020; 382: 20–8. DOI: 10.1056/NEJMoa1817591
  21. Skurihin I.M., Tutelyan V.A. (Eds.). Chemical composition of Russian food products. Moscow; 2002 (in Russ.).
  22. Cacioppo F., Reisenbauer D., Herkner H., Oppenauer J., Schuetz N., Niederdoeckl J. et al. Association of Intravenous Potassium and Magnesium Administration with Spontaneous Conversion of Atrial Fibrillation and Atrial Flutter in the Emergency Department. JAMA Netw Open. 2022; 5 (10): e2237234. DOI: 10.1001/jamanetworkopen.2022.37234
  23. Gronroos N.N., Alonso A. Diet and risk of atrial fibrillation – epidemiologic and clinical evidence. Circ. J. 2010; 74 (10): 2029–38. DOI: 10.1253/circj.cj-10-0820
  24. Mozaffarian D., Stein P.K., Prineas R.J., Siscovick D.S. Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation. 2008; 117: 1130–37. DOI: 10.1161/circulationaha.107.732826
  25. Boos C.J., Anderson R.A., Lip G.Y. Is atrial fibrillation an inflammatory disorder? Eur. Heart J. 2006; 27: 136–49. DOI: 10.1093/eurheartj/ehi780
  26. Calo L., Bianconi L., Colivicchi F., Lamberti F., Loricchio M.L., de Ruvo E. et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J. Am. Coll. Cardiol. 2005; 45: 1723–8. DOI: 10.1177/0115426506021002189
  27. Heidarsdottir R., Arnar D.O., Skuladottir G.V., Torfason B., Edvardsson V., Gottskalksson G. et al. Does treatment with ω-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace. 2010; 12: 356–63. DOI: 10.1093/europace/eup429
  28. Rix T.A., Joensen A.M., Riahi S., LundbyeChristensen S., Tjo/nneland A., Schmidt E.B. et al. A U-shaped association between consumption of marine ω-3 fatty acids and development of atrial fibrillation/atrial flutter – a Danish cohort study. Europace. 2014; 16: 1554–61. DOI: 10.1093/europace/euu019
  29. Eslami M., Badkoubeh R.S., Mousavi M., Radmehr H., Salehi M., Tavakoli N. et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex. Heart Inst. J. 2007; 34: 268–74.
  30. Martínez-González M., Toledo E., Arós F., Fiol M., Corella D., Salas-Salvadó J. et al. Extravirgin olive oil consumption reduces risk of atrial fibrillation: The PREDIMED (Prevención con Dieta Mediterránea) trial. Circulation. 2014; 130: 18–26. DOI: 10.1161/circulationaha.113.006921
  31. Larsson S.C., Drca N., Björck M., Bäck M., Wolk A. Nut consumption and incidence of seven cardiovascular diseases. Heart (Br. Card. Soc.). 2018; 104: 1615–20. DOI: 10.1136/heartjnl-2017- 312819
  32. Khawaja O., Gaziano J.M., Djousse L. Nut consumption and risk of atrial fibrillation in the physicians’ health study. Nutr. J. 2012; 11: 17. DOI: 10.1186/1475-2891-11-17
  33. Conen D., Chiuve S.E., Everett B.M., Zhang S.M., Buring J.E., Albert C.M. Caffeine consumption and incident atrial fibrillation in women. Am. J. Clin. Nutr. 2010; 92: 509–14. DOI: 10.3945/ajcn.2010.29627
  34. Bodar V., Chen J., Gaziano J.M., Albert C., Djoussé L. Coffee consumption and risk of atrial fibrillation in the physicians’ health study. J. Am. Heart Assoc. 2019; 8: e011346. DOI: 10.1161/jaha.118.011346
  35. Bazal P., Gea A., Navarro A.M., Salas-Salvadó J., Corella D., Alonso-Gómez A. et al. Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts. Eur. J. Prev. Cardiol. 2021; 28: 648–57. DOI: 10.1177/2047487320909065
  36. Mostofsky E., Johansen M.B., Lundbye-Christensen S., Tjonneland A., Mittleman M.A., Overvad K. Risk of atrial fibrillation associated with coffee intake: findings from the danish diet, cancer, and health study. Eur. J. Prev. Cardiol. 2016; 23: 922–30. DOI: 10.1177/2047487315624524
  37. Mostofsky E., Berg Johansen M., Tjo/nneland A., Chahal H.S., Mittleman M.A., Overvad K. Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish diet, cancer, and health study. Heart (Br. Card. Soc.). 2017; 103: 1163–7. DOI: 10.1136/heartjnl-2016-310357
  38. Aaseth J., Ellefsen S., Alehagen U., Sundfo/r T.M., Alexander J. Diets and drugs for weight loss and health in obesity – an update. Biomed Pharmacother. 2021; 140: 111789. DOI: 10.1016/j.biopha.2021.111789
  39. Meckling K.A., O’Sullivan C., Saari D. Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women. J. Clin. Endocrinol. Metab. 2004; 89 (6): 2717–23. DOI: 10.1210/jc.2003-031606
  40. Schwingshackl L., Hoffmann G. Comparison of effects of long-term low-fat vs high-fat diets on blood lipid levels in overweight or obese patients: a systematic review and meta-analysis. J. Acad. Nutr. Diet. 2013; 113 (12): 1640–61. DOI: 10.1016/j.jand.2013.07.010
  41. Ludwig D.S., Ebbeling C.B. The carbohydrateinsulin model of obesity: beyond “Calories In, Calories Out”. JAMA Intern. Med. 2018; 178 (8): 1098–103. DOI: 10.1001/jamainternmed.2018. 2933 43. Ludwig D.S., Willett W.C., Volek J.S., Neuhouser M.L. Dietary fat: from foe to friend? Science. 2018; 362 (6416): 764–70. DOI: 10.1126/science.aau2096
  42. Jensen M.D., Ryan D.H., Apovian C.M., Ard J.D., Comuzzie A.G., Donato K.A. et al. American College of Cardiology /American Heart Association Task Force on Practice, S. Obesity 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines and The Obesity Society. J. Am. Coll. Cardiol. 2014; 63 (25 Pt B): 2985–3023.
  43. Zhang S., Zhuang X., Lin X., Zhong X., Zhou H., Sun X. et al. Low-carbohydrate diets and risk of incident atrial fibrillation: a prospective cohort study. J. Am. Heart Assoc. 2019; 8: e011955. DOI: 10.1161/JAHA.119.011955
  44. D’Andrea Meira I., Roma~o T.T., Pires do Prado H.J., Krüger L.T., Pires M.E.P., da Conceic,a ~o P.O. Ketogenic diet and epilepsy: what we know so far. Front Neurosci. 2019; 13: 5. DOI: 10.3389/fnins.2019.00005
  45. Harvey C., Schofield G.M., Zinn C., Thornley S.J., Crofts C., Merien F. Low-carbohydrate diets differing in carbohydrate restriction improve cardiometabolic and anthropometric markers in healthy adults: a randomised clinical trial. Peer J. 2019; 7: 6273. DOI: 10.7717/peerj.6273
  46. Yancy Jr W.S., Olsen M.K., Guyton J.R., Bakst R.P., Westman Jr E.C. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann. Intern. Med. 2004; 140 (10): 769–77. DOI: 10.7326/0003-4819-140-10-200405180-00006
  47. Brinkworth G.D., Noakes M., Buckley J.D., Keogh J.B., Clifton P.M. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am. J. Clin. Nutr. 2009; 90 (1): 23–32. DOI: 10.3945/ajcn.2008.27326
  48. Morales F.E.M., Tinsley G.M., Gordon P.M. Acute and long-term impact of high-protein diets on endocrine and metabolic function, body composition, and exercise-induced adaptations. J. Am. Coll. Nutr. 2017; 36 (4): 295–305. DOI: 10.1080/07315724.2016.1274691
  49. McAuley K.A., Hopkins C.M., Smith K.J., McLay R.T., Williams S.M., Taylor R.W. et al. Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia. 2005; 48 (1): 8–16. DOI: 10.1007/s00125-004-1603-4
  50. De Carvalho K.M.B., Pizato N., Botelho P.B., Dutra E.S., Gonc,alves V. Dietary protein and appetite sensations in individuals with overweight and obesity: a systematic review. Eur. J. Nutr. 2020; 59 (6): 2317–32. DOI: 10.1007/s00394-020-02321-1
  51. Mansoor N., Vinknes K.J., Veiero/d M.B., Rettersto/l K. Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials. Br. J. Nutr. 2016; 115 (3): 466–79. DOI: 10.1017/S0007114515004699
  52. Freire R. Scientific evidence of diets for weight loss: different macronutrient composition, intermittent fasting, and popular diets. Nutrition. 2020; 69: Article 110549. DOI: 10.1016/j.nut.2019.07.001
  53. Sabzwari S., Garg L., Lakkireddy D., Ten J.D. Lifestyle modification approaches to treat atrial fibrillation. Cureus. 2018; 10 (5): e2682. DOI: 10.7759/cureus.2682
  54. Elhayany A., Lustman A., Abel R., Attal-Singer J., Vinker S. A low carbohydrate mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes. Metab. 2010; 12 (3): 204–9. DOI: 10.1111/j.1463-1326.2009.01151.x
  55. Embree G.G., Samuel-Hodge C.D., Johnston L.F., Garcia B.A., Gizlice Z., Evenson K.R. et al. Successful long-term weight loss among participants with diabetes receiving an intervention promoting an adapted Mediterranean-style dietary pattern: the Heart Healthy Lenoir Project. BMJ Open Diabetes. Res. Care. 2017; 5 (1): e000339. DOI: 10.1136/bmjdrc-2016-000339
  56. Esposito K., Maiorino M.I., Bellastella G., Chiodini P., Panagiotakos D., Giugliano D. A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. BMJ Open. 2015; 5 (8): e008222. DOI: 10.1136/bmjopen2015-008222
  57. Martinez-Gonzalez M.A., Gea A., Ruiz-Canela M. The Mediterranean diet and cardiovascular health. Circ. Res. 2019; 124 (5): 779–98. DOI: 10.1161/CIRCRESAHA.118.313348
  58. Jacobs D.J., Gross M.D., Tapsell L.C. Food synergy: an operational concept for understanding nutrition. Am. J. Clin. Nutr. 2009; 89 (5): 1543S–8S. DOI: 10.3945/ajcn.2009.26736B

About Authors

  • Al’fred R. Bogdanov, Dr. Med. Sci., Professor, Rector’s Adviser, Head of Department; ORCID
  • Tat’yana A. Romanova, Cardiologist; ORCID

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery